IndraLab

Statements

YOD1 inhibits Neoplasms. 9 / 9
| 9
reach
"The results revealed that YOD1 knockdown markedly enhanced the growth of subcutaneous tumors (Fig. 1J–L) and the incidence of lung metastasis (Fig. 1M, N) in nude mice and NCG mice."
40274778
reach
"Notably, YOD1 knockdown significantly promoted the proliferation of tumor organoids derived from ccRCC patients (Fig. 2G)."
40274778
reach
"Conversely, increased YOD1 expression blocks ERK signaling by stabilizing TRIM33 activation, thereby inhibiting tumor invasion and lymph node metastasis in squamous cell carcinoma of the head and neck [25]."
40274778
reach
"In another study, overexpression of YOD1 abrogated miR-373-induced cervical cancer progression, including cell proliferation, colony formation in vitro as well as tumor growth assays in vivo [ 17 ]."
33515913
reach
"Knockdown of YOD1 markedly promoted subcutaneous tumor growth (Fig. 7H–J) and lung metastasis (Fig. 7K, L), and these effects were reversed by ZNF24 overexpression."
40274778
reach
"Moreover, YOD1 knockdown promoted tumor growth and metastasis in vitro and in vivo."
40274778
reach
"Overexpression of YOD1 attenuates tumor growth and lymph node metastasis of HNSCC cells in vivo."
37573347
reach
"Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma."
37573347
reach
"The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma."
40274778